BioinksBioprintingMedical AM

3D BioFibR releases two new 3D bioprinting collagen fiber products

μCollaFibR, a bioink additive, and CollaFibR scaffold for 3D cell culture

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

3DBioFibR, a leading innovator in tissue engineering, has released two new collagen fiber products, μCollaFibR (pronounced micro-CollaFibR) and CollaFibR 3D scaffold. Made using 3D BioFibR’s proprietary and new dry-spinning technology to create collagen fibers at commercial scales, these off-the-shelf products offer significant advantages for tissue engineering and tissue culture applications, and are now available for sale, to the scientific and medical communities.

μCollaFibR is a bioink additive for use in the 3D bioprinting of tissue and organ models in a laboratory setting. μCollaFibR mimics the body’s natural cellular scaffold and acts like a biological rebar in bioinks used to print living tissues. When added to bioinks, μCollaFibR improves the mechanical durability of printed tissues so multiple cell types can be assembled, layer-by-layer, to produce highly functional tissue and organ models.

“3D bioprinting is the future of regenerative medicine and it’s exciting to offer μCollaFibR to enhance the capabilities in 3D bioprinting,” said Kevin Sullivan, CEO of 3D BioFibR. “We all want to imagine a future where doctors could just print a kidney, using cells from the patient, instead of having to find a donor match. Our collagen fibers represent a significant improvement over existing scaffolds used in 3D bioprinting, moving the field closer to this reality.”

3DBioFibR releases two new 3D bioprinting collagen fiber products. μCollaFibR, a bioink additive, and CollaFibR scaffold for 3D cell culture.

The CollaFibR scaffold for 3D cell culture allows researchers to study cellular reactions in a more physiologically relevant 3D environment, compared to traditional 2D cultures. The advantage of the CollaFibR scaffold is that it uses GMP type 1 collagen to produce a consistent collagen fiber matrix that resembles the biomechanical and biochemical properties of natural cellular environments.

“Our CollaFibR scaffold allows cells to grow and interact with the surrounding cellular scaffold in 3D, making it ideal for creating realistic tissue constructs for laboratory testing of new drugs and tissue models. Plus, our standard well plate dimensions are compatible with automated equipment for high throughput compound screening and advanced microscopy,” said Sullivan.

Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Edward Wakefield

Edward is a freelance writer and additive manufacturing enthusiast looking to make AM more accessible and understandable.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services


Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.